Topical bevacizumab for neovascular glaucoma: a pilot study.
Waisbourd M, Shemesh G, Kurtz S, Rachmiel R, Moisseiev E, Zayit-Soudri S, Loewenstein A, Barequet I.
Waisbourd M, et al. Among authors: kurtz s.
Pharmacology. 2014;93(3-4):108-12. doi: 10.1159/000358600. Epub 2014 Feb 20.
Pharmacology. 2014.
PMID: 24556733
Clinical Trial.